| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 06/12/2013 | CN103154025A Covalent diabodies and uses thereof |
| 06/12/2013 | CN103153341A Chronic lymphocytic leukemia (Cll) biomarkers |
| 06/12/2013 | CN103153339A Monoclonal antibodies against her2 epitope |
| 06/12/2013 | CN103153331A Humanized antibodies targeting the EC1 domain of cadherin-11 and related compositions and methods |
| 06/12/2013 | CN103149352A Mabuterol colloidal gold test strip and preparation method thereof |
| 06/12/2013 | CN103146715A Mycobacterium tuberculosis ESAT6 antigen protein serial recombinant expression method and application in tuberculosis detection thereof |
| 06/12/2013 | CN103146714A Mycobacterium tuberculosis CFP10 antigen protein serial recombinant expression method and application in tuberculosis detection thereof |
| 06/12/2013 | CN103146710A Yunnan red pear PybMYB gene as well as prokaryotic expression vector and application thereof |
| 06/12/2013 | CN103146709A Yunnan red pear PybHLH gene as well as prokaryotic expression vector and application thereof |
| 06/12/2013 | CN103146708A Il-12/p40 binding proteins |
| 06/12/2013 | CN103146707A Adrenoleukodystrophy related genetic mutant and its detection reagent |
| 06/12/2013 | CN103146652A Anti-olaquindox monoclonal antibody and its hybridoma cell line, preparation methods of antibody and cell line, and kit for detecting olaquindox in forage |
| 06/12/2013 | CN103146651A Test strip capable of testing infectious bovine rhinotracheitis virus (IBRV) by monoclonal antibody mediated nano gold spot infiltration method |
| 06/12/2013 | CN103145844A A ca6 antigen-specific cytotoxic conjugate and methods of using the same |
| 06/12/2013 | CN103145843A Single chain antibody of anti-fibroblast growth factor receptor (anti-FGFR) |
| 06/12/2013 | CN103145842A Il-12/p40 binding proteins |
| 06/12/2013 | CN103145841A Il-12/p40 binding proteins |
| 06/12/2013 | CN103145840A Il-12/p40 binding proteins |
| 06/12/2013 | CN103145839A IL-12/P40 binding proteins |
| 06/12/2013 | CN103145838A IL-12/p40 binding proteins |
| 06/12/2013 | CN103145837A IL-12/P40 binding proteins |
| 06/12/2013 | CN103145836A Anti-myostatin single-chain antibody, and its coding gene, expression vector, recombinant transformant and application |
| 06/12/2013 | CN103145835A Anti-system ASC amino acid transporter 2 (ASCT2) antibody |
| 06/12/2013 | CN103145834A Antibody humanization transformation method |
| 06/12/2013 | CN103145831A Synthesis method of specific salbutamol artificial antigen |
| 06/12/2013 | CN103145807A Hepatitis C virus (HCV) B-cell epitope peptide PUHI37 and application thereof |
| 06/12/2013 | CN103145806A Hepatitis C virus (HCV) B-cell epitope peptide PUHI26 and application thereof |
| 06/12/2013 | CN103145633A Novel melamine antigens and antibody as well as application |
| 06/12/2013 | CN103145566A Artificial ractopamine antigen, preparation method thereof and application |
| 06/12/2013 | CN102618503B Hybrid tumor cell strain 1D7 capable of secreting high neutralizing activity canine distemper virus monoclonal antibody |
| 06/12/2013 | CN102559606B A16 type strain of Coxsackie virus and application of the strain |
| 06/12/2013 | CN102533665B Hybridoma cell strain secreting monoclonal antibody against rice ragged stunt virus and use of monoclonal antibody |
| 06/12/2013 | CN102532307B Method for preparing human immunoglobulin |
| 06/12/2013 | CN102378814B Monoclonal antibody capable of binding to specific discontinuous epitope occurring in ad1 region of human cytomegalovirus gb glycoprotein, and antigen-binding fragment thereof |
| 06/12/2013 | CN102010870B High-expression streptolysin O (SLO) gene as well as secreting expression vector and application thereof |
| 06/12/2013 | CN101925819B Immunodetection assay for mycobacterium tuberculosis complex |
| 06/12/2013 | CN101852804B New applications of antibody of GDF15 (Growth differentiation factor 15) protein |
| 06/12/2013 | CN101687035B Novel compounds |
| 06/12/2013 | CN101588817B Fully human high yield production system for improved antibodies and proteins |
| 06/12/2013 | CN101466737B Targeted binding agents directed to uPAR and uses thereof |
| 06/12/2013 | CN101448858B Combinatorial therapy involving alpha5beta1 antagonists |
| 06/12/2013 | CN101437852B Anti-TAT226 antibodies and immunoconjugates |
| 06/12/2013 | CN101432307B Cytotoxicity mediation of cells evidencing surface expression of CD44 |
| 06/12/2013 | CN101421303B Improved protofibril selective antibodies and the use thereof |
| 06/12/2013 | CN101367875B N-11 truncated amyloid-beta monoclonal antibodies, compositions, methods and uses |
| 06/12/2013 | CN101356194B Antibody molecules having specificity for human IL-6 |
| 06/12/2013 | CN101287492B Anti-glypican-3 antibody |
| 06/12/2013 | CN101198623B Methods and compositions for modulating and detecting WISP activity |
| 06/12/2013 | CN101166976B ELISA assays using prion-specific peptide reagents |
| 06/11/2013 | US8461321 Nucleic acids encoding a deletion variant of uPAR |
| 06/11/2013 | US8461319 Poly-n-acetyl glucosamine (PNAG/dPNAG)-binding peptides and methods of use thereof |
| 06/11/2013 | US8461311 TRAIL trimers, methods and uses therefor |
| 06/11/2013 | US8461310 Anti-ADAM-15 antibodies and utilization of the same |
| 06/11/2013 | US8461309 Inhibitor protein of the wnt signal pathway |
| 06/11/2013 | US8461308 Monoclonal antibodies against prostate specific membrane antigen (PSMA) lacking in fucosyl residues |
| 06/11/2013 | US8461306 Therapeutic use of anti-CS1 antibodies |
| 06/11/2013 | US8461305 L-fucose α1→6 specific lectin |
| 06/11/2013 | US8461304 Antibodies |
| 06/11/2013 | US8461303 LOX and LOXL2 inhibitors and uses thereof |
| 06/11/2013 | US8461298 Compositions and methods for modification of biomolecules |
| 06/11/2013 | US8461109 Method of enhancing the acceptance and/or healing of a skin graft |
| 06/11/2013 | US8460927 B7-H1 antibodies and method of use |
| 06/11/2013 | US8460912 Nucleic acid construct containing full length genome of human hepatitis C virus, recombinant full length virus genome-replicating cells having the nucleic acid construct transferred thereinto and method of producing hepatitis C virus particle |
| 06/11/2013 | US8460891 Monoclonal antibodies detection methods for enzymes that confer resistance to 2,4-dichlorophenoxyacetic acid in plants |
| 06/11/2013 | US8460888 Variable domains of camelid heavy-chain antibodies directed against glial fibrillary acidic proteins |
| 06/11/2013 | US8460675 Viral chemokine-antigen fusion proteins |
| 06/11/2013 | US8460671 Compositions and methods for the therapy and diagnosis of influenza |
| 06/11/2013 | US8460667 EPHA2 receptor antagonist antibodies |
| 06/11/2013 | US8460665 Compositions and methods including a recombinant human MAB that promotes CNS remyelination |
| 06/11/2013 | US8460663 Stabilized liquid anti-RSV antibody formulations |
| 06/11/2013 | US8460662 Compositions and methods relating to anti-IGF-1 receptor antibodies |
| 06/11/2013 | US8460661 Methods of using antibodies that bind the glutamate ligand binding region of Notch1 |
| 06/11/2013 | US8460660 Anti-mesothelin antibodies |
| 06/11/2013 | US8460659 Toll-like receptor 3 antagonists for the treatment of metabolic and cardiovascular diseases |
| 06/11/2013 | US8460657 Modulation of the TrpV: Vps10p receptor system for the treatment of pain |
| 06/11/2013 | CA2533512C Antagonists and agonists of ldcam and methods of use |
| 06/11/2013 | CA2520936C An antibody fragment capable of modulating multidrug resistance and compositions and kits and methods using same |
| 06/11/2013 | CA2498004C Compositions and methods for the diagnosis and treatment of tumor |
| 06/11/2013 | CA2482607C Antibodies, recombinant antibodies, recombinant antibody fragments and fusions mediated plant disease resistance against fungi |
| 06/11/2013 | CA2481349C Peptides for detection of antibody to a. phagocytophilum |
| 06/11/2013 | CA2468733C Antibodies against monocyte chemotactic proteins |
| 06/11/2013 | CA2451002C Cytochrome p-450 gene cluster from rhodococcus ruber and uses thereof in ether fuel cleavage |
| 06/11/2013 | CA2442839C Production and use of novel peptide-based agents for use with bi-specific antibodies |
| 06/11/2013 | CA2437453C Conformationally abnormal forms of tau proteins and specific antibodies thereto |
| 06/11/2013 | CA2407959C Human wingless-like gene |
| 06/11/2013 | CA2407603C Porphyromonas gingivalis recombinant proteins and truncations |
| 06/11/2013 | CA2377381C Neovascular-targeted immunoconjugates |
| 06/11/2013 | CA2267664C Human telomerase reverse transcriptase |
| 06/06/2013 | WO2013082558A1 Immunogenic composition comprising panton-valentine leukocidin (pvl) derived polypeptides |
| 06/06/2013 | WO2013082366A1 Anti-ceacam1 recombinant antibodies for cancer therapy |
| 06/06/2013 | WO2013082282A1 Anti-il-1beta (interleukin-1beta) antibody-based prophylactic therapy to prevent complications leading to vaso-occlusion in sickle cell disease. |
| 06/06/2013 | WO2013081993A1 Anti-glucagon antibodies and uses thereof |
| 06/06/2013 | WO2013081612A1 Vectors and host cells comprising a modified sv40 promoter for protein expression |
| 06/06/2013 | WO2013081463A2 Influenza a virus specific antibodies |
| 06/06/2013 | WO2013081371A1 Binding molecule generated from human b-cells and capable of neutralizing influenza a viruses |
| 06/06/2013 | WO2013081233A1 Cell killing fusion peptide exhibiting tumor cell-specific necrosis induction and tumor regression |
| 06/06/2013 | WO2013081143A1 Drug containing carrier into cell for forming immune complex |
| 06/06/2013 | WO2013081091A1 Drug for producing radiolabeled polypeptide reducing non-specific renal accumulation |
| 06/06/2013 | WO2013081037A1 IgA-BINDING PEPTIDE AND PURIFICATION OF IgA THEREBY |
| 06/06/2013 | WO2013080811A1 Biomarker for lymphocytic infundibuloneurohypophysitis, and use applications thereof |